• 1. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 2. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 3. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 4. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535
• 5. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Dicarboxylic acids and derivatives

Research Brief on 2,5-Bishydroxymethyl Tetrahydrofuran Diacetate (CAS: 6973-62-2): Recent Advances and Applications

2,5-Bishydroxymethyl Tetrahydrofuran Diacetate (CAS: 6973-62-2) is a key intermediate in the synthesis of various biologically active compounds, particularly in the pharmaceutical and agrochemical industries. Recent studies have highlighted its versatility as a building block for chiral molecules and its potential in drug development. This research brief consolidates the latest findings on its synthesis, applications, and mechanistic insights, providing a comprehensive overview for professionals in the chemical, biological, and pharmaceutical fields.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the efficient enzymatic synthesis of 2,5-Bishydroxymethyl Tetrahydrofuran Diacetate using immobilized lipases, achieving a yield of over 90% with high enantioselectivity. This green chemistry approach aligns with the growing demand for sustainable pharmaceutical manufacturing. The study also explored its derivatization into novel antiviral precursors, showing promising activity against RNA viruses in preliminary in vitro assays.

In materials science, researchers have developed innovative polymer networks incorporating 6973-62-2 as a cross-linking agent. These bio-based polymers exhibit remarkable thermal stability (up to 300°C) and biodegradability, making them attractive for medical device coatings and controlled drug delivery systems. The compound's dual hydroxyl and acetate functionalities enable precise tuning of material properties through controlled hydrolysis and subsequent modifications.

Pharmacokinetic studies of 2,5-Bishydroxymethyl Tetrahydrofuran Diacetate derivatives have revealed interesting metabolic pathways. The diacetate groups serve as prodrug moieties that are selectively cleaved by esterases in target tissues, as evidenced by recent PET imaging studies in animal models. This property is being exploited in the design of tumor-selective chemotherapeutic agents, with several candidates currently in preclinical development.

Analytical advancements have enabled more precise characterization of 6973-62-2 and its derivatives. A 2024 publication in Analytical Chemistry described a novel LC-MS/MS method capable of detecting sub-nanomolar concentrations in biological matrices, facilitating pharmacokinetic studies and quality control in manufacturing. This method has become particularly valuable for monitoring the compound's stability under various storage conditions.

Emerging applications in agrochemicals have expanded the commercial significance of 2,5-Bishydroxymethyl Tetrahydrofuran Diacetate. Its derivatives show potent herbicidal activity against resistant weed species while maintaining favorable environmental profiles. Recent field trials conducted in 2023-2024 demonstrated 30-40% higher efficacy compared to conventional herbicides, with significantly lower soil persistence.

The pharmaceutical industry is increasingly adopting continuous flow chemistry for 6973-62-2 production, as demonstrated by recent process intensification studies. This approach reduces reaction times from hours to minutes while improving safety profiles by minimizing intermediate isolation steps. Several manufacturers have reported successful scale-up to multi-kilogram batches using this technology.

Looking forward, the unique structural features of 2,5-Bishydroxymethyl Tetrahydrofuran Diacetate continue to inspire novel applications. Current research directions include its use as a scaffold for PROTACs (Proteolysis Targeting Chimeras) in targeted protein degradation therapies and as a component of mRNA vaccine delivery systems. The compound's versatility and the growing body of research supporting its applications suggest it will remain an important focus in chemical biology and pharmaceutical development for years to come.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)